Skip to content

Clinical trials

Completed Myelodysplastic Syndromes trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Completed Country / region: Denmark Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20091
20103
20132
20142
20151
20162
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Novartis Pharmaceuticals2
Astex Pharmaceuticals, Inc.1
Celgene Corporation1
Daniel El Fassi1
Fred Hutchinson Cancer Center1
GlaxoSmithKline1
Nordic MDS Group1
Rigshospitalet, Denmark1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes15
Leukemia, Myeloid, Acute3
Leukemia, Myelomonocytic, Chronic3
Anemia1
Anemia, Aplastic1
Anemia, Diamond-Blackfan1
Anemia, Refractory, with Excess of Blasts1
Cytopenia1
Dyskeratosis Congenita1
Fanconi Anemia1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.